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lypican (GPC)-3 inhibits cell proliferation and
regulates cell survival during development. This
action is demonstrated by GPC3 loss-of-function
mutations in humans and mice. Here, we show that the
GPC3 core protein is processed by a furinlike convertase. This
processing is essential for GPC3 modulating Wnt signaling
and cell survival in vitro and for supporting embryonic cell
movements in zebraﬁsh. The processed GPC3 core protein
is necessary and sufﬁcient for the cell-speciﬁc induction of
apoptosis, but in vitro effects on canonical and noncanonical
G
 
Wnt signaling additionally require substitution of the core
protein with heparan sulfate. Wnt 5A physically associates
only with processed GPC3, and only a form of GPC3 that
can be processed by a convertase is able to rescue epiboly
and convergence/extension movements in GPC3 morphant
embryos. Our data imply that the Simpson–Golabi–Behmel
syndrome may in part result from a loss of GPC3 controls
on Wnt signaling, and suggest that this function requires
the cooperation of both the protein and the heparan sulfate
moieties of the proteoglycan.
 
Introduction
 
Loss-of-function mutations of 
 
GPC3
 
, the gene that encodes
glypican (GPC)-3, cause Simpson–Golabi–Behmel syndrome
(SGBS) in humans. This X-linked syndrome is characterized
by prenatal and postnatal overgrowth, visceral and skeletal
anomalies, and an increased risk for the development of
embryonal tumors (Pilia et al., 1996). The clinical features
of these patients and the phenotypes of two independently
generated 
 
Gpc3
 
 knockout mouse models (Cano-Gauci et al.,
1999; Paine-Saunders et al., 2000) suggest that GPC3 inhibits
cell proliferation and regulates cell survival during develop-
ment, but the mechanisms involved remain unclear. Based
on the phenotypic similarity of SGBS and the Beckwith–
Wiedemann syndrome, it has been proposed that GPC3
might interfere with insulin-like growth factor (IGF) II
signaling (Pilia et al., 1996), but crossbreeds of 
 
Gpc3
 
   
 
and 
 
Igf
 
-deficient mouse strains suggest an IGF-independent
overgrowth mechanism in the Gpc3 knockout mice (Chiao
et al., 2002). More consistent is the genetic evidence in flies,
mice, 
 
Xenopus laevis
 
, and zebrafish that implicates GPCs in
the regulation of Wingless/Wnt and Dpp/Bmp signaling,
pathways that direct cell fates, migration, and proliferation
during embryogenesis and in adult tissues (Jackson et al.,
1997; Paine-Saunders et al., 2000; Baeg et al., 2001; Grisaru
et al., 2001; Topczewski et al., 2001; Tsuda et al., 2001;
Fujise et al., 2003; Ohkawara et al., 2003).
Only limited information is available on the molecular
and cellular mechanisms that support this signaling function
(Song and Filmus, 2002). GPCs are heparan sulfate pro-
teoglycans (HSPGs) that are linked to the cell surface via
glycosylphosphatidylinositol (GPI). As such, GPCs qualify
as receptors or coreceptors for several heparin-binding pro-
teins including morphogens, growth factors, adhesion, and
matrix molecules; and they are potentially involved in shap-
ing the concentration gradients and activity ranges of these
molecules. Yet, the distinctive part of a GPC is its protein core.
Six GPCs (GPC1–6) have been identified in vertebrates, two
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in 
 
Drosophila melanogaster
 
, and one in 
 
Caenorhabditis elegans
 
.
All GPC core proteins have a similar domain structure, start-
ing with a signal peptide, followed by a large globular cys-
teine-rich domain (CRD), a smaller stalk-like domain with
the heparan sulfate (HS) attachment sites, and, finally, a sig-
nal sequence for GPI attachment. 14 cysteines, in concert
with several additional amino acids that occur at invariant po-
sitions, compose a unique sequence motif that has been
strictly conserved in all GPCs, suggesting some highly con-
served specific function for the CRD. Recently, Chen and
Lander (2001) have demonstrated that the CRD of GPC1
strongly influences the HS substitution of the core protein.
GPCs are constitutively shed from the surfaces of cultured
cells, but it is not clear whether this involves phospholipase
activities that cleave the GPI anchor and/or protease activi-
ties that cleave at the level of the stalk domain. It is also not
known whether shedding represents a physiological process,
and whether this might down-regulate these molecules or
render their functions non-cell autonomous. Yet, membrane
anchorage is required for GPC3 to induce cell lineage-spe-
cific apoptosis (Gonzalez et al., 1998). Here, we report that
GPC3 is subjected to endoproteolytic processing. This pro-
cessing is distinct from the shedding step because it occurs in
the CRD. It generates two core protein subunits, designated
as 
 
 
 
 and 
 
 
 
, which remain in association with one another
through disulfide bonding, and with the cell surface via the
GPI-tail of the 
 
 
 
 subunit. This processing is mediated by
members of the proprotein convertase (PC) family, and is es-
sential for GPC3 to modulate Wnt signaling in cultured
cells, to induce apoptosis in specific cell types via the activa-
tion of c-Jun NH
 
2
 
-terminal protein kinase (JNK), and to
support epiboly and convergence/extension movements in
zebrafish gastrulae.
 
Results
 
Endoproteolytic processing of GPC3
 
To characterize GPC3, we introduced an HA epitope into
the NH
 
2
 
 terminus of the protein. In MDCK cells that stably
expressed this construct, most of HA-GPC3 was converted
into proteoglycan (Fig. 1 A, left, lane 1). After heparitinase
digestion (with or without an additional chondroitinase ABC
digestion), nonreduced GPC3 yielded a protein core of 
 
 
 
65
kD (lanes 2 and 4). In contrast, under reducing conditions,
we mainly detected a discrete 
 
 
 
40 kD HA-tagged band (lane
5). Heparitinase and chondroitinase ABC treatments had no
influence on the apparent molecular mass of this band (lanes
6–8). From this, we tentatively concluded that the protein
core of GPC3 might consist of two disulfide-linked subunits,
 
Figure 1.
 
Posttranslational modification of GPC3 in MDCK cells.
 
 
Total proteoglycan or GPC3 isolated from stable transfectant cells 
was treated with heparitinase (Hase), chondroitinase ABC (Case), or 
endoglycosidase H (Endo H) as indicated, and fractionated by SDS-
PAGE under reducing (DTT) or nonreducing conditions. (A) Two-
subunit structure of GPC3. Western blots of total proteoglycan 
extract, using rat anti-HA mAb 3F10 to detect GPC3, and anti-
 
 
 
HS 
mAb 3G10 to detect the desaturated uronates that are generated by 
heparitinase and that remain in association with the core proteins. 
(B) Time course of the GPC3 maturation. Cells were pulse labeled 
with [
 
35
 
S]cysteine-methionine for 10 min and chased for the indi-
cated time periods. GPC3 from cell lysates, isolated using anti-HA 
antibody, was detected by autoradiography. Unreduced (left) and 
reduced (right) non enzyme-treated samples (top), and reduced 
glycosidase-treated samples (bottom) reveal that the HS substitution, 
proteolytic processing, and Endo H–resistant N-glycosylation of 
GPC3 follow similar time courses. (C) Inhibition of GPC3 processing 
by blocking ER export or calcium depletion. Cells were incubated 
for 6 h with (
 
 
 
) or without (
 
 
 
) 30 
 
 
 
M BFA or 2 
 
 
 
M A23187, pulse-
labeled for 10 min, and chased for 60 min. GPC3 immunopurified 
from cell lysate was detected by autoradiography. (D) Endoproteolytic 
processing of GPC3
 
 
 
HS. Labeled HA-GPC3
 
 
 
HS was immunopre-
cipitated from the cell lysate (lanes 1 and 3) and the conditioned 
medium (lanes 2 and 4). Braces show glycanated GPC3, curved 
arrowheads indicate the GPC3 core protein, arrows indicates the 
 
 
 
40-kD NH
 
2
 
-terminal (HA-tagged) 
 
 
 
-subunit, and arrowheads 
indicate the COOH-terminal 
 
  
 
subunit that is separated from the 
 
 
 
-subunit by reduction. Numbers on the left represent molecular 
mass markers.T
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whereby the NH
 
2
 
-terminal (
 
 
 
) subunit has a size of 
 
 
 
40 kD
(HA-tagged fragment) and the COOH-terminal (
 
 
 
) sub-
unit, with the sites for the attachment of the HS chains, has a
size of 
 
 
 
30 kD. Consistently, after heparitinase digestion,
such a 
 
  
 
subunit could be detected with 3G10, an mAb spe-
cific for a neo-epitope that includes the 
 
 
 
-glucuronate gener-
ated by the enzyme (Fig. 1 A, right, compare lanes 2 and 4
with 6 and 8). Shed GPC3 accumulating in the conditioned
culture media of these cells was also an endoproteolytically
processed HSPG (unpublished data).
The time course of the proteolytic maturation of GPC3
was analyzed by a series of pulse-labeling and chase experi-
ments, and related to other posttranslational modifications
of the protein. Proteolytic maturation, acquisition of endo
H-resistance, and substitution with HS followed similar time
courses (Fig. 1 B). Treatment with Brefeldin A (BFA) inhib-
ited both the HS substitution and the proteolytic processing
of GPC3 (Fig. 1 C), indicating the requirement for a post-
ER compartment. Both posttranslational modifications were
also inhibited by the calcium ionophore A23187 (Fig. 1 C),
suggesting the involvement of calcium-dependent cisternal
enzymes. Finally, an HS-deficient mutant (GPC3
 
 
 
HS), cre-
ated by mutating the serines at the two potential HS attach-
ment sites into alanines, was also normally processed in two
subunits (Fig. 1 D). The 
 
 
 
 subunits from both the cell ex-
tract and the conditioned medium migrated as 
 
 
 
40 kD frag-
ments. However, the 
 
  
 
subunit from the cell extract mi-
grated slightly more slowly than its counterpart from the
conditioned medium (Fig. 1 D, compare lane 3 with lane 4).
This suggests a second proteolytic event, potentially related
to the shedding of GPC3 from the cell surface. Together,
these data suggest a scheme whereby GPC3 is synthesized as
a proprotein in the ER, where it is transferred to GPI and
N-glycosylation is initiated. Then, it shuttles to the Golgi
complex, where it is further N-glycosylated, O-glycanated,
and processed into two subunits, and travels to the cell sur-
face. Ultimately, a second proteolytic event separates the
protein from the GPI anchor, and the protein is shed.
 
Endoproteolytic processing of GPC3 depends on a 
paired basic motif in the CRD
 
To identify the processing site, we mutated four potential
protease-cleavage consensus sequences in GPC3. All of
these sequences are located between Cys
 
349
 
 and Lys
 
405
 
, po-
tentially yielding an NH
 
2
 
-terminal HA-tagged fragment of
 
 
 
40 kD (Fig. 2 A). All mutants were tested by transient
transfection in CHO-K1 cells. Processing was abolished
in the GPC3/AQYA mutant, but unaffected in the three
Figure 2. Identification of the cleavage site in GPC3. (A) Schematic representation of GPC3. The GPC3 domains are depicted as shaded boxes. 
Lines within the boxes denote cysteine residues of the CRD, as conserved in all glypicans (GPCs). Open arrowheads denote potential N-glyco-
sylation sites; closed arrowheads indicate the positions of the HS attachment sites. The curved arrowhead indicates the position of the 
proteolytic cleavage site. This latter site occurs in a region of the CRD that shows low sequence similarity to corresponding regions in other 
GPCs. Amino acid substitutions, as indicated in bold, were introduced into this unconserved region (UR) and in the HS substitution domain 
(GAG), either alone or in combination. SP, signal peptide for membrane translocation; HA, hemagglutinin tag; CRD, cysteine-rich domain; 
GPI, signal peptide for glypiation. (B) Endoproteolytic processing of the GPC3 mutants. Whole extracts of CHO-K1 cells transiently transfected 
with a control vector, wild-type GPC3 or mutant forms of GPC3, were fractionated by SDS-PAGE under reducing conditions, and analyzed 
by Western blotting using rat anti-HA mAb 3F10. (C–F) Subcellular localization of GPC3 and GPC3/AQYA. Horizontal confocal sections of 
stable MDCK clones expressing GPC3 (top) or GPC3/AQYA (bottom), fixed and stained with rat anti-HA mAb 3F10, without (left) or after 
permeabilization (right). Bar, 10  m. (G) Glycanation and endoproteolytic processing of GPC3/AQYA. Proteoglycan isolated from stably 
transfected MDCK cells was treated with the indicated enzymes, fractionated by SDS-PAGE under reducing and nonreducing conditions, and 
analyzed by Western blotting using rat anti-HA mAb 3F10. (H) Maturation of GPC3/AQYA. Stable transfectant MDCK cells were pulse labeled 
with [
35S]cysteine-methionine for 10 min and chased for the indicated time periods. Mutant GPC3, immunopurified from cell lysate, was 
treated with the indicated enzymes, fractionated by SDS-PAGE under reducing conditions, and detected by auroradiography. Braces show 
glycanated GPC3/AQYA; curved arrowheads indicate the GPC3/AQYA core protein. Numbers on the left represent molecular mass markers.T
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other mutants (Fig. 2 B, lanes 2–6). To further identify
R
 
355
 
QYR
 
358
 
 as the cleavage site and as a paired basic mo-
tif, we tested two additional mutants, GPC3/RQYA and
GPC3/AQYR. Both mutants yielded only unprocessed
forms of GPC3 (Fig. 2 B, lanes 7–8).
The repercussions of these mutations in terms of intracel-
lular trafficking, proteolytic processing, and HS substitution
were further analyzed in stably transfected MDCK cells.
Both GPC3 and GPC3/AQYA accumulated at the cell sur-
face (Fig. 2, C and D). Compilations of series of confocal
images along the z axis revealed that both forms of GPC3
were accumulating over both the apical and basolateral
membranes of the cells (unpublished data). The removal of
the cleavage site had no influence on the substitution of the
core protein with HS-chains (Fig. 2 G) and on the HS-chain
charge densities of GPC3 (not depicted). Pulse labeling and
chase experiments showed no change in the time course of
the endo H-sensitivity of GPC3/AQYA (compare Fig. 2 H
with Fig. 1 B). Therefore, the inability of transfected cells to
process GPC3/AQYA cannot be attributed to gross impair-
ments of the transport kinetics or trafficking routes followed
by the mutant, and we conclude it genuinely reflects the re-
moval of the cleavage site.
 
Endoproteolytic processing of GPC3 is mediated by PCs
 
The sequence R
 
355
 
QYR
 
358
 
 in GPC3 fits the PC recognition
motif (Arg/Lys-(X)
 
n
 
-Arg/Lys, where n 
 
  
 
2, 4, or 6; and X is
any amino acid except Cys and rarely Pro). Four members of
the PC family, PACE4, PC6, LPC, and furin, have been im-
plicated in the processing of substrates in the constitutive
secretory pathway (Taylor et al., 2003). 
 
 
 
1
 
PDX is an engi-
neered mutant of 
 
 
 
1
 
 antitrypsin with an altered active loop,
displaying an Arg-X-X-Arg motif that acts specifically as a
bait region for intracellular PCs (Creemers et al., 2001). As
shown in Fig. 3 A, transient cotransfection with 
 
 
 
1
 
PDX in-
hibited the processing of both GPC3 (lanes 2 and 4) and
GPC3
 
 
 
HS, the HS-deficient mutant (lanes 3 and 5). Furin-
mediated processing would be consistent with the effect of
BFA, A23187, and 
 
 
 
1
 
PDX on GPC3 processing. As a test
for the implication of furin itself, we expressed GPC3 in
RPE.40 cells, a furin-deficient CHO cell line. RPE.40 cells
were unable to process GPC3 (Fig. 3 B, lane 2) unless
cotransfected with furin expression vector (Fig. 3 B, lane 4).
Substitution of GPC3 with HS, which is acquired in the
trans-Golgi compartment, occurred to a similar extent in
both CHO-K1 and RPE.40 cells, again implying that the
transport and glycosylation of GPC3 are grossly normal in
the absence of proteolytic processing. Although these results
strongly suggest that furin is involved in GPC3 processing in
CHO cells, other members of the PC family might also res-
cue this processing. Therefore, RPE.40 cells were transfected
with GPC3 and a panel of PCs that have broad tissue distri-
butions, including PACE4, PC6 (isoforms A and B), and
LPC. Cotransfection with PC6A and PC6B also resulted in
cleavage of GPC3 (Fig. 3 C, lanes 3 and 4). The best pro-
cessing rates were observed for furin, followed by the two
isoforms of PC6, whereas PACE4 and LPC cleaved GPC3
only to a limited extent (Fig. 3 C, lanes 2 and 5). In a further
experiment, we tested whether furin can directly process
GPC3. We treated stably transfected MDCK cells with BFA
to inhibit the processing, and pulse-labeled these cells for 10
min. After a chase of 60 min, GPC3 was immunopurified
from the cell extract and digested in vitro with recombinant
furin. Autoradiography revealed that GPC3 was processed in
two subunits (Fig. 3 D, lane 2).
 
GPC3-induced apoptosis depends on processing 
by PCs and on JNK activation
 
Some types of cells that are transfected with GPC3 undergo
apoptosis. The induction of this apoptosis does not require
the HS chains of GPC3 (Gonzalez et al., 1998). To evalu-
ate whether proteolytic processing of GPC3 is necessary,
MCF-7 cells were transiently transfected with control vec-
tors GPC3, GPC3/AQYA, or GPC3
 
 
 
HS. We confirmed
that these constructs were expressed and, except for GPC3/
AQYA, processed in these cells (unpublished data). By mor-
phological criteria, a vector control yielded only 2% of ap-
optotic nuclei. After transfection of GPC3 or GPC3
 
 
 
HS,
Figure 3. Identification of PCs as GPC3-processing enzymes. 
(A) PC-dependent processing in CHO-K1 cells. CHO-K1 cells were 
transfected with empty expression vector alone (lane 1), with GPC3 
or GPC3 HS and empty vector, or with GPC3 or GPC3 HS, and 
with an  1-PDX expression vector. Total cell extracts were fractionated 
by SDS-PAGE under reducing conditions and analyzed by Western 
blotting using anti-HA mAb. (B) Furin-mediated processing in RPE.40 
cells. RPE.40 cells were transfected with empty vector, GPC3 or 
GPC3/AQYA, alone or in combination with a furin expression vector. 
Western blot analysis of reduced samples using anti-HA antibody. 
(C) PC-mediated processing in RPE.40 cells. RPE.40 cells were 
transfected with empty vector only (lane 1) or with GPC3 together 
with LPC, PC6A, PC6B, and PACE4. Western blot analysis of 
reduced samples using anti-HA antibody. (D) In vitro digestion of 
GPC3 with recombinant furin. GPC3 was immunoprecipitated 
from BFA-treated metabolically labeled transfectant MDCK cells. 
The immunoprecipitates were mock-digested or digested with 
recombinant furin, fractionated by SDS-PAGE under reducing 
conditions, and detected by autoradiography. The curved arrow-
head indicates the core protein, the arrow indicates the  -subunit, 
and the arrowhead indicates the COOH-terminal   subunit. 
Numbers on the left represent molecular mass markers.T
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27–30% of the cells displayed typical apoptotic nuclear
morphology. In contrast, when transfected with GPC3/
AQYA, only 3% of the cells underwent apoptosis (Fig. 4 A).
Measuring for the amount of cytoplasmic histone-associated
DNA fragments also indicated that GPC3/AQYA was much
less effective at inducing apoptosis than wild-type GPC3 or
GPC3
 
 
 
HS (Fig. 4 B). Thus, lack of processing by conver-
tases nearly abolishes the capacity of the GPC3 protein to
induce apoptosis in MCF-7 cells.
Several stimuli that lead to apoptosis activate MAPKs.
Looking for potential effectors, we found that GPC3 overex-
pression in MCF-7 cells results in the phosphorylation of
both the 46- and 55-kD isoforms of JNK (Fig. 4 C). There
was no effect on ERK or p38. In contrast, overexpression of
GPC3/AQYA did not significantly activate any of these ki-
nases. MAPK Kinase 4 (MKK4) is upstream of JNK, and is
essential for the full activation of JNK (Davis, 2000). MCF-7
cells cotransfected with dominant-negative MKK4 underwent
42% less apoptosis than cells transfected with only GPC3
(Fig. 4 D), suggesting JNK activation is critical for GPC3-
induced apoptosis. Significantly, overexpression of GPC4,
tested as an additional control for specificity, did not activate
JNK or induce apoptosis in MCF-7 cells (unpublished data).
 
PC-processed GPC3 modulates Wnt signaling in vitro
 
GPCs have been implicated in the canonical Wnt signaling
pathway, in 
 
D. melanogaster 
 
(Baeg et al., 2001), and in the
JNK-dependent convergent extension/planar cell polarity
pathway, in zebrafish (Topczewski et al., 2001). Therefore,
we examined the effect of GPC3 on Wnt signaling. To test
for canonical 
 
 
 
-catenin–mediated signaling, we measured
the activities of the 
 
 
 
-catenin/TCF-responsive reporter
pTOPFLASH (Korinek et al., 1997) and the mutant re-
porter pFOPFLASH. Wnt1, constitutively active 
 
 
 
-catenin,
DVL-1, and, to a lesser extent, Wnt5A and Wnt7A acti-
vated the pTOPFLASH reporter, both in CHO-K1 (Fig.
5 A) and MCF-7 cells (not depicted). By themselves,
GPC3, GPC3/AQYA, or GPC3
 
 
 
HS did not activate
pTOPFLASH (Fig. 5 A). Yet, at invariant levels of Wnt1 in
cotransfection mixtures, increasing the amount of wild-type
Figure 4. GPC3-induced apoptosis. (A and B) Apoptosis depends 
on GPC3 processing. MCF-7 cells were transiently transfected with 
a  -galactosidase expression vector and a fivefold excess of control 
vector, or vectors encoding GPC3, GPC3/AQYA, or GPC3 HS. (A) 
Apoptosis scored by nuclear morphology. The results (mean   SEM) 
are shown as a percentage of apoptotic cells (the total number of 
scored cells taken as 100%). (B) Apoptosis scored by cell death 
ELISA assay. The results (mean   SEM) are shown as fold increase in 
apoptosis, compared with cells transfected with control vector. 
(C) Processed GPC3 activates JNK. MCF-7 cells were transfected 
as in A and B. Normalized cell extracts were analyzed by Western 
blotting, using either anti–phospho-MAPK antibodies or the respective 
anti-MAPK antibodies. Total cell extracts from UV-treated NIH/3T3 
cells were taken as positive control. (D) Apoptosis depends on JNK 
activation. MCF-7 cells were triple transfected with  -galactosidase 
expression vector, pcDNA3.1 containing either a dominant-negative 
MKK4 construct or no insert, and a control vector or a vector encoding 
GPC3. Apoptosis was measured 48 h after transfection by the cell 
death ELISA assay, as in B.
Figure 5. Processed GPC3 modulates Wnt-initiated canonical 
signaling. (A) Activation of  -catenin/TCF-dependent transcription 
by Wnts and Wnt signal transduction components. CHO-K1 cells 
were transfected with 0.2  g of the TOPFLASH or FOPFLASH 
reporter plasmid, 0.2  g of  -galactosidase expression vector, and 
0.4  g of the indicated expression plasmids. (B and C) GPC3 over-
expression inhibits Wnt signaling, upstream of Dishevelled. CHO-
K1 cells were transfected with 0.2  g of the TOPFLASH reporter 
plasmid, 0.2  g of  -galactosidase vector, and 0.4  g Wnt1,  -cat, 
or DVL expression vector, along with (from left to right) either 0.2, 
0.4, or 0.8  g of GPC3 or mutant forms of GPC3, as indicated. Empty 
pDisplay plasmid was added to equalize the total amount of DNA 
used for transfection. (D) Inhibition of Wnt signaling depends on PC 
processing. RPE.40 cells were transfected with 0.2  g of the TOP-
FLASH or FOPFLASH reporter plasmid, 0.2  g of  -galactosidase 
expression vector, and 0.4  g of furin expression vector, along with 
varying amounts of GPC3 and empty pDisplay plasmid, as in B and C. 
Data represent mean   standard error.T
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GPC3 repressed Wnt1-mediated pTOPFLASH activation
in a dose-dependent manner. In contrast, the GPC3/AQYA
or the GPC3 HS mutant had no effect on Wnt1-induced
signaling (Fig. 5 B). Moreover, neither GPC3 (Fig. 5 C),
nor GPC3/AQYA (not depicted), nor GPC3 HS (not de-
picted) had any effect on pTOPFLASH reporter activity in-
duced by the overexpression of DVL-1 or constitutively ac-
tive  -catenin. Together, these results indicate that GPC3
interferes with Wnt/ -catenin signaling upstream of Di-
shevelled, and suggest that PC processing of the GPC core
protein is required for this effect. To confirm this sugges-
tion, pTOPFLASH activity was also measured in furin-defi-
cient CHO cells (RPE.40 cells). As predicted, dose-depen-
dent suppression of canonical Wnt signaling by GPC3 in
these cells was dependent on the inclusion of a furin expres-
sion construct in the transfections (Fig. 5 D).
To test for effects of GPC3 on the activation of nonca-
nonical Wnt signaling pathways, we monitored the activa-
tion of the c-Jun–dependent transcription factor AP-1. Lu-
ciferase reporter constructs driven by an AP-1–responsive
promotor were strongly activated by dominant-positive
Cdc-42 (ninefold increase) and by Wnt5A (fivefold in-
crease), and less efficiently by Wnt1 (twofold increase), both
in CHO-K1 cells and in MCF-7 cells (Fig. 6 A). In CHO-
K1 cells, where GPC3 does not induce apoptosis, GPC3,
GPC3/AQYA or GPC3 HS, and also GPC4, by them-
selves, did not activate the AP-1–luciferase reporter (Fig. 6
A). Importantly, at constant levels of Wnt5A, a potent acti-
vator of noncanonical signaling, increasing levels of GPC3
resulted in a dose-dependent decrease in luciferase activity.
Increasing concentrations of GPC3/AQYA or GPC3 HS
had no effect (Fig. 6 C). Together, these results indicate that
GPC3 overexpression suppresses noncanonical Wnt signal-
ing in CHO-K1 cells, and suggest that PC processing of the
GPC core protein is required also for this effect. This was
confirmed by AP-1 reporter assays in RPE.40 cells, where
dose-dependent suppression of Wnt5A signaling was depen-
dent on the cotransfection of furin (Fig. 6 E). In contrast, in
MCF-7 cells, where GPC3 or GPC3 HS expression suffices
to stimulate JNK phosphorylation and induce apoptosis
(Fig. 4), AP-1–luciferase activity was stimulated by GPC3
(threefold) and GPC3 HS (twofold). GPC3/AQYA and
Figure 6. Processed GPC3 modulates noncanonical Wnt signaling. (A) Activation of AP-1–dependent transcription by Wnts and GPC3. 
MCF-7 or CHO-K1 cells were transfected with 0.2  g of the AP-1–responsive reporter and 0.2  g of  -galactosidase expression vector, along 
with 0.4  g of the indicated expression plasmids. (B) GPC3 dose-dependent activation of AP-1 in MCF-7 cells depends on the processed core 
protein. MCF-7 cells were transfected with AP-1 reporter plasmid and  -galactosidase (as in A), and (from left to right) 0.2, 0.4, or 0.8  g of 
GPC3 or its mutants, as indicated. Empty pDisplay plasmid was added to equalize the total amount of DNA used for transfection. (C and D) 
GPC3 effects on noncanonical Wnt signaling. CHO-K1 cells or MCF-7 cells were transfected with the AP-1–responsive reporter and  -galactosidase 
(as in A) and 0.4  g of Wnt5A expression vector (only 0.2  g for MCF-7 cells), along with varying amounts of GPC3 or its mutants, and empty 
pDisplay plasmid (as in B). Wnt inhibition in CHO cells depends on processing and on HS substitution. In MCF-7 cells, processed proteoglycan 
or core protein further enhances AP-1–dependent transcription. (E) Inhibition of noncanonical Wnt signaling depends on PC processing. 
RPE.40 cells were transfected with 0.2  g of the AP-1–responsive reporter, 0.2  g of  -galactosidase expression vector, 0.4  g of furin 
expression plasmid along with varying amounts of GPC3 and empty pDisplay plasmid (as in B). (A–E) Data represent mean   standard error. 
(F) Wnt–GPC3 association depends on processing and on HS substitution. MCF-7 cells were cotransfected with HA-tagged Wnt5A or Wnt7A 
in combination with HA-tagged wild-type GPC3, GPC3/AQYA, GPC3 HS, or GPC4. Immunoprecipitates obtained with anti-GPC3/4 polyclonal 
antibodies were fractionated by SDS-PAGE under reducing conditions, and analyzed by Western blotting, using monoclonal anti-HA antibody. 
The positive controls are total extracts from Wnt5A/7A-transfected cells. Note that like GPC3, GPC4 is also composed of two disulfide-linked 
subunits. The upper smear (brace) represents the glycanated form of GPC3. The curved arrowhead indicates the unprocessed core protein, and 
the arrow indicates the  -subunit. The open arrowhead points to the HA-tagged form of Wnt5A, and the asterisk denotes the IgG heavy chain. 
Numbers represent molecular mass markers.T
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GPC4, which do not induce apoptosis, had no significant
effects on AP-1–luciferase activity (Fig. 6 A). By themselves,
GPC3 and GPC3 HS, but not GPC3/AQYA, activated the
AP-1–responsive reporter in a dose-dependent manner (Fig.
6 B). In further contrast to CHO-K1 cells, increasing the
levels of GPC3 or GPC3 HS in cotransfections with
Wnt5A resulted in a dose-dependent further increase in lu-
ciferase activity, but GPC3/AQYA had no effect (Fig. 6 D).
Surmising a functional interaction between Wnt5A and pro-
cessed GPC3, we tested whether in MCF-7 cells, GPC3
might associate with Wnt5A, possibly in a PC-processing–
dependent way. Using specific anti-GPC antibodies, we iso-
lated GPCs from MCF-7 cells that were cotransfected with
Wnts and GPCs, and probed for the presence of GPCs and
Wnts in the immunoprecipitates, using anti-HA antibodies
(Fig. 6 F). Wnt5A (but not Wnt7A) coprecipitated with
wild-type GPC3, but not with GPC3 HS, GPC3/AQYA,
or GPC4. These results indicate that, as for the effects of
GPC3 on noncanonical signaling in CHO-K1 cells, a stable
association between GPC3 and Wnt5A in MCF-7 cells re-
quires both PC processing and substitution with HS, and is
specific for GPC3. Altogether, these results identify GPC3
as a regulator of Wnt signaling and indicate that PC process-
ing of the core protein is required for this property.
Interfering with GPC3 processing disrupts gastrulation 
movements in zebrafish
To establish the relevance of our findings for the in vivo
functions of GPC3, we examined the significance of GPC3
and GPC3 processing for early zebrafish development. We
identified a cDNA corresponding to zebrafish GPC3 (Gen-
Bank/EMBL/DDBJ accession number AY346090), encod-
ing a protein that is highly similar to GPC3 from other ver-
tebrates, including the characteristic domain structure and a
consensus sequence for cleavage by PCs (Fig. 7 A). The HA-
tagged wild-type form of zebrafish GPC3 undergoes pro-
teolytic processing in CHO-K1 cells, but zebrafish GPC3/
AVSA, a form that is mutant for the R
348VSR
351 PC-cleav-
age consensus sequence, does not (Fig. 7 B). In situ hybrid-
izations revealed that GPC3 is maternally expressed and near
ubiquitous during blastula and early gastrula stages, but be-
comes restricted to the prospective hindbrain by 24 hours
post fertilization (hpf; Fig. 7 C and not depicted). To inves-
tigate the function of GPC3 during zebrafish development,
we blocked endogenous GPC3 expression by the injection of
antisense morpholino oligonucleotides (5 ng/embryo). Two
Figure 7. Interference with GPC3 expression disrupts gastrulation 
movements in zebrafish. (A) Predicted domain structure of GPC3 
and similarities to GPC3 sequences from other vertebrates. 
(B) Endoproteolytic processing of the zebrafish GPC3. Whole extracts 
of CHO-K1 cells transiently transfected with wild-type zebrafish 
GPC3 or mutant forms, designed not to interact with the morpholinos 
(GPC3*) and not to be proteolytically processed (GPC3*/AVSA), 
were analyzed as described in Fig. 2 B. The upper smear (brace) 
represents the glycanated form of GPC3. The curved arrowhead 
indicates the unprocessed core protein, and the arrow indicates the 
 -subunit. Numbers represent molecular mass markers. (C) Expression 
of GPC3 at 50% epiboly spreads throughout the animal pole. 
Detection by in situ hybridization, lateral view with animal pole up. 
(D–M) Analysis of the GPC3 morphant phenotype at 10 hpf. (D–G) 
Lateral views of living embryos injected with control mispair (5-mis 
MO) and antisense morpholinos (MO). Animal pole is to the left and 
dorsal is up. Note the arrest of blastoderm movement toward the 
vegetal pole (brace). (H–M) Dorsal views of control (H, J, and L) and 
morphant (I, K, and M) embryos. The expressions of three marker 
genes, indicated at top right, are analyzed by in situ hybridization. 
Animal pole is to the left. No tail (ntl) staining reveals marked 
shortening (arrows), thickening (curved arrowheads), and undulations 
of the notochord in the morphants. The shape of the neuroectoderm 
is outlined by the expression of distal-less3 (dlx3). Note the broadened 
(curved arrowheads) and shortened neural plate. Widening of paraxial 
protocadherin (papc) expression reflects a reduced convergence of 
presomitic mesoderm. (N–P) Correction of the effects of antisense 
morpholino MO1 by coinjection of GPC3 mRNA lacking MO-target 
sequences. Injection of MO1 causes gastrulation defects (less than 
80% epiboly at 10 hpf), and the majority of the embryos are dead 
by 12 hpf. GPC3* mRNA rescues gastrulation and embryo survival 
(N), and corrects the expression pattern of the ntl marker gene (O). 
GPC3*/AVSA mRNA, encoding a GPC3 protein that cannot be 
processed, fails to do so (N and P). Results (means and standard 
errors) of three separate experiments (n, total number of embryos 
analyzed). Bars, 250  m.T
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different antisense morpholinos, and their respective 5-mis-
pair controls were tested. The first (MO1) was directed
against the exon 2 splice donor site, to block zygotic pre-
mRNA splicing. The second (MO2) was targeted to the
start codon and 5  untranslated region, to block GPC3
mRNA translation. Injection of MO1 or MO2 caused se-
vere defects during epiboly, an early movement that drives
cells toward the vegetal pole to cover the entire yolk by the
end of gastrulation. While the blastoderm was spread over
the entire yolk in control-injected embryos (100% epiboly),
at 10 hpf most of the MO-injected embryos were arrested at
60–80% epiboly (Fig. 7, D–G). The majority of these em-
bryos died a few hours later (Fig. 7 N).
Tracing the expression of several marker genes further
documented morphogenetic abnormalities. The expression
domain of ntl in the chordamesoderm was shortened and
widened in MO-injected embryos (Fig. 7, H and I). The ex-
pression domain of dlx3, marking the boundaries of the neu-
roectoderm, revealed a mediolateral broadening of the neu-
ral plate during early segmentation (Fig. 7, J and K).
Widening of the papc expression reflected reduced conver-
gence of presomitic mesoderm (Fig. 7, L and M). These
results indicate that GPC3 plays essential roles during gas-
trulation by affecting cell movements without significantly
contributing to early cell fate specification. None of the
5-mispair control morpholinos had such effects. The speci-
ficity of the MO effects was further documented by “rescue”
experiments. Whereas  80% of the MO-injected embryos
exhibited gastrulation defects, coinjection of 1 pg RNA en-
coding full-length HA-tagged zebrafish GPC3, so designed
to not interact with the morpholinos, significantly reduced
this figure to  15% (Fig. 7 N). To evaluate the importance
of GPC3 processing for function, we coinjected 1 pg of
RNA encoding GPC3/AVSA mutant protein. Unlike wild-
type GPC3 (Fig. 7, N and O), this mutant did not rescue
embryo morphogenesis or survival (Fig. 7, N and P). These
results indicate that loss of GPC3 function affects cell move-
ments during gastrulation, and that abolishing the pro-
teolytic processing of GPC3 blocks normal GPC3 function.
Discussion
HS is strongly implicated in the control of normal cell
growth and development, regulating events ranging from
branching morphogenesis to left–right patterning (Lander
and Selleck, 2000). Most explored in the context of devel-
opment is its contribution to FGF and Wnt signaling. In
GPCs, this versatile HS is linked to highly conserved pro-
teins with complex structures, but with no known func-
tions other than controlling the display of HS at the cell
surface. Genetic evidence has identified GPCs as media-
tors of the canonical Wg signaling pathway in D. mela-
nogaster (Tsuda et al., 1999; Baeg et al., 2001), and as
mediators of the “Wnt–polarity” pathway that regulates
movements of convergent extension in X. laevis and ze-
brafish (Topczewski et al., 2001; Ohkawara et al., 2003).
In this paper, we identify an endoproteolytic processing of
the GPC3 core protein. This processing is mediated by
PCs and is necessary for the modulation of Wnt signaling,
for cell type-specific negative effects on cell survival that
implicate JNK activation, and for the regulation of gastru-
lation movements in zebrafish.
GPC3 clearly influences both canonical and noncanonical
Wnt signaling in vitro. It acts upstream of Dishevelled, and
can be recovered in physical association with Wnts, which
would be consistent with a role in ligand reception, captur-
ing the ligands and controlling their availability for interac-
tion with cognate receptors that transduce the signal. The
processed core protein is essential, but not sufficient, for this
activity, as modulation of Wnt signaling and physical associ-
ation with Wnt do not occur unless the processed protein is
substituted with HS. It has already been pointed out that the
CRD of the GPCs bears some structural resemblance to the
CRD of the Frizzled Wnt receptors (Topczewski et al.,
2001). The PC cleavage site occurs just downstream of this
region of homology. Therefore, one possible scheme could
be that the processing facilitates the interaction of the Frz
motif in the CRD with one or several members of the Wnt
family. In that case, the data would suggest that the intrinsic
affinity of the exposed protein-binding site is too weak, and
that binding needs the Wnt ligand also to be bound to an
HS chain that forms part of the proteoglycan, the chain and
the protein acting as the two stems of molecular tweezers
that withhold the ligand.
Although GPC3 inhibits Wnt signaling in our cellular
bioassays, it is not clear whether overexpressions represent
physiological assessments of function. Wnts are important
regulators of cell growth and survival, and there seems to be
an important role for inhibition of Wnt signaling in re-
sponse to different stress signals that all converge on the acti-
vation of c-Jun and apoptosis in vivo (Grotewold and Ru-
ther, 2002). In some cells or cellular contexts, one possible
consequence of an overabundance of GPC3 tweezers could
be that they withdraw Wnts from antiapoptotic signaling
cascades. Yet, although excess Wnt or downstream Wnt
signal transduction components are counterbalancing the
apoptosis of MCF-7 cells (unpublished data), this scheme is
not a sufficient explanation for the apoptosis that is initiated
by GPC3 in these cells. Indeed, unlike in the inhibition of
Wnt signaling, a bare, unsubstituted core protein suffices for
inducing this apoptosis, provided it is processed by PCs.
Therefore, we propose that processing also exposes a GPC3
core protein determinant that interacts directly, and without
assistance of any HS, with another, as yet unidentified cell-
specific component, and that in appropriate contexts the
formation of this complex initiates a signaling cascade that
converges on JNK activation and apoptosis. Proposing that
the processed core protein of GPC3 also impinges on signal-
ing paths other than those activated by Wnts would be con-
sistent with the genetic evidence that identifies Dally and
GPC3 as enhancers of Dpp/Bmp4 signaling (Jackson et al.,
1997; Tsuda et al., 1999; Paine-Saunders et al., 2000;
Grisaru et al., 2001; Fujise et al., 2003).
Functional and genetic studies in D. melanogaster have im-
plicated JNK as a component of the Wnt–polarity pathway.
More recently, it was shown that JNK also plays a role in reg-
ulating convergent extension movements during gastrulation
in vertebrate embryos (Yamanaka et al., 2002). GPC3, which
can modulate pathways that control the activation of JNK,
appears important for the control of gastrulation movementsT
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in zebrafish. The GPC3 morphant phenotype, with misposi-
tioning of the expressions of the mesendoderm/neuroecto-
derm-specific genes ntl, papc, and dlx3, resembles the pheno-
types of embryos with loss-of-function mutations in wnt11/
silberblick, wnt5A/pipetail, and GPC4/knypek (Rauch et al.,
1997; Heisenberg et al., 2000; Topczewski et al., 2001).
Therefore, the data would fit the idea that GPC3 is required
for receiving Wnt5A or Wnt11 signals and activating nonca-
nonical Wnt pathways leading to JNK, similar to the role of
knypek in convergence/extension. However, unlike knypek/
GPC4, GPC3 also has an effect on epiboly, suggesting non-
overlapping functions for the various GPCs. Future experi-
ments, addressing genetic interactions with Wnts, should
clarify the validity of this proposal.
Patients with loss-of-function mutations of GPC3 and
Gpc3-deficient mice show generalized overgrowth, and some
of the clinical manifestations of the SGBS (e.g., syndactyly
and supernumerary nipples) strongly suggest locally defective
apoptotic signaling programs. Patients with SGBS often de-
velop embryonal tumors (neuroblastoma and Wilms’ tumor),
and loss of GPC3 expression has been reported in several tu-
mors (Lin et al., 1999; Xiang et al., 2001). Inhibition of Wnt
signals that are involved in cell proliferation and cell survival,
and direct effects on apoptotic signaling cascades, could be
physiological roles of GPC3; this is consistent with the in
vitro data that help explain these phenotypes and the implica-
tion of GPC3 as a potential tumor suppressor. Because these
roles depend on PC processing, failure or absence of process-
ing may explain possible expression paradoxes (Midorikawa et
al., 2003). Fitting GPC3 in signaling pathways will have to
consider that its loss or overexpression might represent the
loss or gain of an HS moiety that potentially impinges on
many ligands and pathways, and of a unique protein that may
be dedicated to more unique functions. The expressions of
the various GPCs show substantial overlap (Veugelers et al.,
2000). In case of loss, compensating HSPG expressions may
easily rescue the HS deficit, whereas rescue of the dedicated
function may critically depend on the nature of the protein
core, which does or does not share this function with GPC3,
and, possibly, its relationship as substrate to proprotein-con-
verting enzymes in the tissues. In this context, we have pre-
liminary evidence that GPC4, which does not induce apopto-
sis in MCF-7 cells, is processed by PCs in MCF-7 and other
cells. In contrast, GPC5, the GPC that is most closely related
to GPC3, is not processed and also does not induce apoptosis
in these cells (unpublished data). Inspection of the sequences
of the various GPCs indicates that they all contain potential
PC-cleavage sites at corresponding levels in their CRDs; cur-
rently, we are exploring whether unique GPC–PC substrate–
enzyme relationships might exist. Indeed, the members of the
PC family display similar, but not identical, specificity for ba-
sic motifs at the cleavage site of their substrates. Processing
may also be regulated. With respect to Dally, there is no con-
clusive evidence explaining how Dally affects Wg signaling in
some tissues and Dpp in others. Whereas tissue-specific dif-
ferences in HS structure were proposed, perhaps tissue-spe-
cific differences in PC-mediated processing have to be consid-
ered as one additional possibility.
Our current experiments aim at addressing these various
issues, but the data in the present paper strongly argue that
endoproteolytic processing of the GPC core proteins by PCs
is essential for their signaling activities.
Materials and methods
Plasmid constructs
All cDNAs were introduced into pDisplay or pcDNA (Invitrogen). The HA-
tagged GPC3 construct has been described previously (Veugelers et al.,
2000). QuickChange (Stratagene) was used to modify GPC3. In all cases,
mutagenesis was confirmed by sequencing. PC expression vectors were
described previously (Creemers et al., 2001). The  1PDX-cDNA was pro-
vided by G. Thomas (Oregon Health Sciences University, Portland, OR)
and dominant-negative MKK4 was a gift of P. Agostinis (University of Leu-
ven, Leuven, Belgium). Wnt expression vectors were provided by J. Kita-
jewski (Columbia University, New York, NY). The DVL-1 and DVL-1 dele-
tion mutants were provided by P. Salinas (Imperial College of Science,
London, UK). The  N90 stabilized  -catenin construct was obtained from
S. Tejpar (University of Leuven, Leuven, Belgium). The pTOPFLASH and
pFOPFLASH reporter constructs were gifts of H. Clevers (Hubrecht Labora-
tory, Utrecht, Netherlands). The AP-1 reporter construct was provided by
M. Baens (University of Leuven, Leuven, Belgium). The activated form of
Cdc42 was obtained from A. Hall (University College, London, UK).
Cell culture and transfections
Cells were routinely grown in 6-well plates, in DME/F12 supplemented
with 10% FBS (Hyclone). MDCK cells were transfected by electroporation,
and stable transfectants were selected as described previously (Mertens et
al., 1996). COS-1, CHO-K1, and RPE.40 cells were transfected using Lipo-
fectAMINE PLUS (Invitrogen). Transient transfection assays in MCF-7 cells
were conducted as described by Gonzalez et al. (1998).
Apoptosis assays
Cells were transfected with  -galactosidase expression vector (Promega)
and a fivefold excess of pDisplay vector, without insert or encoding wild-
type or mutant GPC3. The serum was removed 12 h after transfection, and
apoptosis was scored 36 h after serum withdrawal. Cells grown on glass
coverslips were fixed in 4% PFA for 30 min, stained with DAPI (Sigma-
Aldrich), and examined by fluorescence microscopy. Apoptotic nuclei were
counted in at least 10 fields, with a minimum of 100 cells per field. Cells
grown in 6-well plates were scored by cell death ELISA assay (Roche).
Detection of MAPKs
The medium was removed 12 h after transfection, and the cells were fur-
ther grown for 12 h in DME/F12 supplemented with 1% FBS. Cells were
washed, and lysed in ice-cold homogenization buffer (50 mM  -glycero-
phosphate, pH 7.3, 1.5 mM EGTA, 1.0 mM EDTA, 0.1 mM sodium vana-
date, 1.0 mM benzamidine, 10  g/ml aprotinin, 10  g/ml leupeptin, 2.0
 g/ml pepstatin A, and 10 mM DTT) containing 1% Triton X-100. Cleared
cell lysates, normalized for  -galactosidase activity, were fractionated by
electrophoresis in 10% SDS-PAGE (Bio-Rad Laboratories) and transferred
to Hybond C-extra membranes (Amersham Biosciences). The membranes
were probed with mouse anti–phospho-ERK1/2, rabbit anti–phospho-p38,
rabbit anti-p38 (New England Biolabs, Inc.), rabbit anti-JNK, rabbit anti–
phospho-JNK (Upstate Biotechnology), and rabbit anti-ERK1/2 (Sigma-
Aldrich) diluted in blocking buffer (TBS; 0.1% Tween-20 and 5% nonfat
dry skim milk). Bound antibody was detected with species-specific sec-
ondary antiserum conjugated with peroxidase, using an ECL detection sys-
tem (Amersham Biosciences).
Proteoglycan extraction and detection
Extraction buffers containing Triton X-100 or octylglucoside, and proce-
dures used to isolate the proteoglycans from cell extracts or media frac-
tions were performed as described previously (Lories et al., 1989). Samples
(normalized for number of cells) were fractionated by SDS-PAGE under re-
ducing or nonreducing conditions and transferred to cationic nylon mem-
branes (Bio-Rad Laboratories). HA-tagged proteins were detected with the
rat mAb 3F10 (Roche). Binding of primary antibody was detected with goat
anti–rat secondary antibody conjugated to alkaline phosphatase (Calbio-
chem), the chemiluminescent substrate CSPD, and Nitro-Block-II™ Lumi-
nescence Enhancer (Applied Biosystems).
Metabolic labeling and immunoprecipitation
After a preincubation in methionine- and cysteine-free DME supplemented
with 0.1% BSA (Sigma-Aldrich) for 30 min at 37 C, cells were labeled forT
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10 min in similar medium containing 100  Ci/ml of [
35S]cysteine-methio-
nine (ICN Biomedicals), followed by a chase in DME/F12 supplemented
with 10% FCS for the times indicated. Cells were lysed in OG extraction
buffer. Cleared cell lysates were preabsorbed with protein A–Sepharose
(Amersham Biosciences) for 30 min at 4 C, and then incubated with 10  g
of the mouse anti-HA mAb (12CA5; Roche) coupled to protein A–Sepha-
rose for 3 h at 4 C. The beads were washed with OG extraction buffer, and
bound material was eluted by boiling in 1% SDS for 5 min.
Enzyme treatments
Proteoglycan extracts were dialyzed against enzyme buffer and digested
with chondroitinase ABC or heparitinase (Seikagaku) as described previ-
ously (Lories et al., 1989). Digested immunoprecipitates were aliquoted
and treated with endoglycosidase H (Roche) or furin (Affinity BioReagents,
Inc.) as recommended by the manufacturers.
Confocal laser scanning microscopy
Stable MDCK clones were fixed with 4% PFA in 0.1 M phosphate buffer
for 30 min at 25 C. Where indicated, the cells were permeabilized with
0.1% Triton X-100. After blocking, the cells were incubated with rat anti-
HA mAb 3F10 for 2 h at 25 C. Binding of primary antibody was detected
with Alexa 594–conjugated anti–rat IgG (Molecular Probes) by confocal
laser scanning microscopy (model MRC 1024; Bio-Rad Laboratories).
Luciferase assays for TOP/FOPFLASH and AP-1 reporter activities
MCF-7 or CHO-K1 cells were transiently transfected with a combination of
plasmids as described the legends to Figs. 5 and 6. Cells were lysed 24 h
after transfection. Luciferase (Promega) and  -galactosidase (Applied Bio-
systems) assays were performed as specified by the manufacturers. For
each experiment, the transfections were performed in triplicate. The results
are represented as the means   SD of at least three independent experi-
ments (nine separate transfections). All values were normalized for trans-
fection efficiency ( -galactosidase activity).
Wnt-GPC coimmunoprecipitation experiments
Synthetic peptides (corresponding to the amino acid residues 50–65 of
GPC3 and 67–82 of GPC4) were used to raise and isolate affinity-puri-
fied GPC-specific rabbit polyclonal antibodies (Eurogentec). OG ex-
tracts of transfected MCF-7 cells were cleared and preabsorbed as de-
scribed in Metabolic labeling and immunoprecipitation, and mixed
overnight with a fresh sample of protein A-Sepharose and 10  g of anti-
GPC3 or anti-GPC4.
Approaches in zebrafish
Zebrafish were kept and bred according to standard protocols (Westerfield,
1995). The zebrafish GPC3 EST clone (ICRFp524K17141Q8) was pur-
chased from RZPD. GPC3 constructs for RNA injection were generated by
PCR and cloned into pCS2 . Capped mRNA was synthesized in vitro from
linearized plasmids, using the mMESSAGE mMACHINE SP6 kit (Ambion).
FITC-conjugated antisense morpholinos with the sequences 5 -TAGCA-
GAAACTCACCTTGAAAGAGG-FITC-3  (MO1) and 5 -ATAAGGCTTCCA-
GATGACAGGTTTG-FITC-3  (MO2), and the respective FITC-conjugated
5-mispair antisense control morpholinos (5-mis MO) were obtained from
Gene Tools, LLC. RNA and/or antisense morpholinos were injected into
one- or two-cell stage embryos. Embryos with a homogenous fluorescence
were collected at 4 hpf and scored when controls reached bud stage (10
hpf). Embryos reaching   80% epiboly by that time were scored as “gas-
trulation-defective.” Whole-mount in situ hybridization was performed as
described by Jowett (2001), using the indicated probes.
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